+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Diseases Drugs Market Research Reports

Fed Microbials - Global Strategic Business Report - Product Thumbnail Image

Fed Microbials - Global Strategic Business Report

  • Report
  • November 2024
  • 309 Pages
  • Global
From
Dermatophytic Onychomycosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Dermatophytic Onychomycosis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Pneumonia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 100 Pages
  • Global
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 291 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • November 2024
  • 116 Pages
  • Global
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 164 Pages
  • Global
From
Tuberculosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tuberculosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 283 Pages
  • Global
From
Tinea Pedis (Athlete`s Foot) Treatment - Global Strategic Business Report - Product Thumbnail Image

Tinea Pedis (Athlete`s Foot) Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 284 Pages
  • Global
From
Herpes Simplex Virus Infections - Global Strategic Business Report - Product Thumbnail Image

Herpes Simplex Virus Infections - Global Strategic Business Report

  • Report
  • November 2024
  • 269 Pages
  • Global
From
Antivirals Drug - Global Strategic Business Report - Product Thumbnail Image

Antivirals Drug - Global Strategic Business Report

  • Report
  • November 2024
  • 172 Pages
  • Global
From
Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 208 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Vancomycin - Global Strategic Business Report - Product Thumbnail Image

Vancomycin - Global Strategic Business Report

  • Report
  • November 2024
  • 78 Pages
  • Global
From
Influenza Medication - Global Strategic Business Report - Product Thumbnail Image

Influenza Medication - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Hospital Acquired Infection Treatment - Global Strategic Business Report - Product Thumbnail Image

Hospital Acquired Infection Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global Strategic Business Report - Product Thumbnail Image

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Oral Antiviral Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Drug Class, Indication, Distribution Channel, Region, By Country: 2020-2030 - Product Thumbnail Image

Oral Antiviral Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Drug Class, Indication, Distribution Channel, Region, By Country: 2020-2030

  • Report
  • July 2024
  • 296 Pages
  • Global
From
Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Thumbnail Image

Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • May 2024
  • 250 Pages
  • Global
From
Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 135 Pages
  • Global
From
Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market. Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans. Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more